Business Description
Check-Cap Ltd
ISIN : IL0011336851
Total Employee Number:
85Description
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but plans to market products in the United States, Europe, Israel and Japan.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 13.69 | |||||
Equity-to-Asset | 0.46 | |||||
Debt-to-Equity | 0.01 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EPS without NRI Growth Rate | 51.3 | |||||
3-Year FCF Growth Rate | 87.3 | |||||
3-Year Book Growth Rate | -58.9 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 35.11 | |||||
9-Day RSI | 37.17 | |||||
14-Day RSI | 38.34 | |||||
3-1 Month Momentum % | -22.78 | |||||
6-1 Month Momentum % | -19.65 | |||||
12-1 Month Momentum % | 77.07 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.05 | |||||
Quick Ratio | 0.05 | |||||
Cash Ratio | 0.05 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.3 | |||||
Shareholder Yield % | 0.68 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | 216 | |||||
ROA % | 91.14 | |||||
ROIC % | -58.02 | |||||
3-Year ROIIC % | 477.36 | |||||
ROC (Joel Greenblatt) % | 6553.03 | |||||
ROCE % | 224.4 | |||||
Years of Profitability over Past 10-Year | 1 | |||||
Moat Score | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 1.76 | |||||
PB Ratio | 2.37 | |||||
Price-to-Tangible-Book | 2.97 | |||||
Price-to-Free-Cash-Flow | 72.51 | |||||
Price-to-Operating-Cash-Flow | 72.51 | |||||
EV-to-EBIT | 2.03 | |||||
EV-to-EBITDA | 2.03 | |||||
EV-to-Forward-Revenue | 4.55 | |||||
EV-to-FCF | -190.54 | |||||
Earnings Yield (Greenblatt) % | 49.26 | |||||
FCF Yield % | -0.51 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:MBAI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Check-Cap Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | 0.66 | ||
| Beta | 0.0245 | ||
| 3-Year Sharpe Ratio | 0.14 | ||
| 3-Year Sortino Ratio | 0.37 | ||
| Volatility % | 201.08 | ||
| 14-Day RSI | 38.34 | ||
| 14-Day ATR ($) | 0.108843 | ||
| 20-Day SMA ($) | 1.2565 | ||
| 12-1 Month Momentum % | 77.07 | ||
| 52-Week Range ($) | 0.593 - 3.92 | ||
| Shares Outstanding (Mil) | 7.73 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Check-Cap Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Check-Cap Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-13 | In 122 days | ||
| General meeting for 2025 | 2026-10-16 10:00 | In 95 days | ||
| Second quarter earnings results for 2026 | 2026-08-17 | In 34 days | ||
| First quarter earnings results for 2026 | 2026-07-13 | 1.22 (+1.67%) | ||
| Northland Growth Conference | 2026-06-17 09:00 | 1.36 (-6.21%) | ||
| Annual report for 2025 | 2026-04-27 | 1.53 (+3.38%) | ||
| General meeting for 2024 | 2025-10-17 10:00 | 2.09 (+6.09%) | ||
| Annual report for 2024 | 2025-08-27 | 0.63 (+1.64%) | ||
| Second quarter earnings results for 2024 | 2024-12-31 | 1.15 (+10.58%) | ||
| 0.05:1 Stock Split | 2022-11-25 | 4.64 (-0.22%) |
Show
Entries
Check-Cap Ltd Frequently Asked Questions
What is Check-Cap Ltd(MBAI)'s stock price today?
The current price of MBAI is $1.16. The 52 week high of MBAI is $3.92 and 52 week low is $0.59.
When is next earnings date of Check-Cap Ltd(MBAI)?
The next earnings date of Check-Cap Ltd(MBAI) is 2026-08-17 Est..
Does Check-Cap Ltd(MBAI) pay dividends? If so, how much?
Check-Cap Ltd(MBAI) does not pay dividend.
Guru Commentaries on NAS:MBAI
No articles.
Press Release
Articles on Check-Cap Ltd
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers